_version_ 1784579923137003520
author Sellner, Leopold
Schetelig, Johannes
Koster, Linda
Choi, Goda
Blaise, Didier
Beelen, Dietrich
Schianca, Fabrizio Carnevale
Passweg, Jakob
Schanz, Urs
Gyan, Emmanuel
Sora, Federica
Kröger, Nicolaus
Wulf, Gerald. G.
Van Gorkom, Gwendolyn
Mayer, Jiri
Orvain, Corentin
Bourhis, Jean Henri
Jindra, Pavel
Potter, Victoria
Zallio, Francesco
Vandenberghe, Elisabeth
Robinson, Stephen
Hayden, Patrick J.
Yakoub-Agha, Ibrahim
Montoto, Silvia
Dreger, Peter
author_facet Sellner, Leopold
Schetelig, Johannes
Koster, Linda
Choi, Goda
Blaise, Didier
Beelen, Dietrich
Schianca, Fabrizio Carnevale
Passweg, Jakob
Schanz, Urs
Gyan, Emmanuel
Sora, Federica
Kröger, Nicolaus
Wulf, Gerald. G.
Van Gorkom, Gwendolyn
Mayer, Jiri
Orvain, Corentin
Bourhis, Jean Henri
Jindra, Pavel
Potter, Victoria
Zallio, Francesco
Vandenberghe, Elisabeth
Robinson, Stephen
Hayden, Patrick J.
Yakoub-Agha, Ibrahim
Montoto, Silvia
Dreger, Peter
author_sort Sellner, Leopold
collection PubMed
description
format Online
Article
Text
id pubmed-8497266
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-84972662021-10-22 Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey Sellner, Leopold Schetelig, Johannes Koster, Linda Choi, Goda Blaise, Didier Beelen, Dietrich Schianca, Fabrizio Carnevale Passweg, Jakob Schanz, Urs Gyan, Emmanuel Sora, Federica Kröger, Nicolaus Wulf, Gerald. G. Van Gorkom, Gwendolyn Mayer, Jiri Orvain, Corentin Bourhis, Jean Henri Jindra, Pavel Potter, Victoria Zallio, Francesco Vandenberghe, Elisabeth Robinson, Stephen Hayden, Patrick J. Yakoub-Agha, Ibrahim Montoto, Silvia Dreger, Peter Bone Marrow Transplant Correspondence Nature Publishing Group UK 2020-05-22 2020 /pmc/articles/PMC8497266/ /pubmed/32444863 http://dx.doi.org/10.1038/s41409-020-0946-x Text en © The Author(s) 2020, corrected publication 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Sellner, Leopold
Schetelig, Johannes
Koster, Linda
Choi, Goda
Blaise, Didier
Beelen, Dietrich
Schianca, Fabrizio Carnevale
Passweg, Jakob
Schanz, Urs
Gyan, Emmanuel
Sora, Federica
Kröger, Nicolaus
Wulf, Gerald. G.
Van Gorkom, Gwendolyn
Mayer, Jiri
Orvain, Corentin
Bourhis, Jean Henri
Jindra, Pavel
Potter, Victoria
Zallio, Francesco
Vandenberghe, Elisabeth
Robinson, Stephen
Hayden, Patrick J.
Yakoub-Agha, Ibrahim
Montoto, Silvia
Dreger, Peter
Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey
title Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey
title_full Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey
title_fullStr Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey
title_full_unstemmed Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey
title_short Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey
title_sort idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an ebmt survey
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497266/
https://www.ncbi.nlm.nih.gov/pubmed/32444863
http://dx.doi.org/10.1038/s41409-020-0946-x
work_keys_str_mv AT sellnerleopold idelalisibexposurebeforeallogeneicstemcelltransplantationinpatientswithfollicularlymphomaanebmtsurvey
AT scheteligjohannes idelalisibexposurebeforeallogeneicstemcelltransplantationinpatientswithfollicularlymphomaanebmtsurvey
AT kosterlinda idelalisibexposurebeforeallogeneicstemcelltransplantationinpatientswithfollicularlymphomaanebmtsurvey
AT choigoda idelalisibexposurebeforeallogeneicstemcelltransplantationinpatientswithfollicularlymphomaanebmtsurvey
AT blaisedidier idelalisibexposurebeforeallogeneicstemcelltransplantationinpatientswithfollicularlymphomaanebmtsurvey
AT beelendietrich idelalisibexposurebeforeallogeneicstemcelltransplantationinpatientswithfollicularlymphomaanebmtsurvey
AT schiancafabriziocarnevale idelalisibexposurebeforeallogeneicstemcelltransplantationinpatientswithfollicularlymphomaanebmtsurvey
AT passwegjakob idelalisibexposurebeforeallogeneicstemcelltransplantationinpatientswithfollicularlymphomaanebmtsurvey
AT schanzurs idelalisibexposurebeforeallogeneicstemcelltransplantationinpatientswithfollicularlymphomaanebmtsurvey
AT gyanemmanuel idelalisibexposurebeforeallogeneicstemcelltransplantationinpatientswithfollicularlymphomaanebmtsurvey
AT sorafederica idelalisibexposurebeforeallogeneicstemcelltransplantationinpatientswithfollicularlymphomaanebmtsurvey
AT krogernicolaus idelalisibexposurebeforeallogeneicstemcelltransplantationinpatientswithfollicularlymphomaanebmtsurvey
AT wulfgeraldg idelalisibexposurebeforeallogeneicstemcelltransplantationinpatientswithfollicularlymphomaanebmtsurvey
AT vangorkomgwendolyn idelalisibexposurebeforeallogeneicstemcelltransplantationinpatientswithfollicularlymphomaanebmtsurvey
AT mayerjiri idelalisibexposurebeforeallogeneicstemcelltransplantationinpatientswithfollicularlymphomaanebmtsurvey
AT orvaincorentin idelalisibexposurebeforeallogeneicstemcelltransplantationinpatientswithfollicularlymphomaanebmtsurvey
AT bourhisjeanhenri idelalisibexposurebeforeallogeneicstemcelltransplantationinpatientswithfollicularlymphomaanebmtsurvey
AT jindrapavel idelalisibexposurebeforeallogeneicstemcelltransplantationinpatientswithfollicularlymphomaanebmtsurvey
AT pottervictoria idelalisibexposurebeforeallogeneicstemcelltransplantationinpatientswithfollicularlymphomaanebmtsurvey
AT zalliofrancesco idelalisibexposurebeforeallogeneicstemcelltransplantationinpatientswithfollicularlymphomaanebmtsurvey
AT vandenbergheelisabeth idelalisibexposurebeforeallogeneicstemcelltransplantationinpatientswithfollicularlymphomaanebmtsurvey
AT robinsonstephen idelalisibexposurebeforeallogeneicstemcelltransplantationinpatientswithfollicularlymphomaanebmtsurvey
AT haydenpatrickj idelalisibexposurebeforeallogeneicstemcelltransplantationinpatientswithfollicularlymphomaanebmtsurvey
AT yakoubaghaibrahim idelalisibexposurebeforeallogeneicstemcelltransplantationinpatientswithfollicularlymphomaanebmtsurvey
AT montotosilvia idelalisibexposurebeforeallogeneicstemcelltransplantationinpatientswithfollicularlymphomaanebmtsurvey
AT dregerpeter idelalisibexposurebeforeallogeneicstemcelltransplantationinpatientswithfollicularlymphomaanebmtsurvey
AT idelalisibexposurebeforeallogeneicstemcelltransplantationinpatientswithfollicularlymphomaanebmtsurvey